BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7863710)

  • 1. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
    Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J
    Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
    Haushofer A; Halbmayer WM; Dittel M; Prachar H; Mlczoch J; Fischer M
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):697-706. PubMed ID: 7865675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
    Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
    Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
    Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
    Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2.
    Haude M; Hafner G; Jablonka A; Rupprecht HJ; Prellwitz W; Meyer J; Erbel R
    Am Heart J; 1995 Aug; 130(2):228-38. PubMed ID: 7631600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of F(1+2) prothrombin fragments and thrombin - antithrombin III (TAT) complexes in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Gwieździński Z; Kotschy M
    Med Sci Monit; 2002 Aug; 8(8):BR324-7. PubMed ID: 12165736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion.
    Rifón J; Páramo JA; Prósper F; Collados MT; Sarrá J; Rocha E
    Hematol Pathol; 1994; 8(1-2):35-42. PubMed ID: 8034556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.